Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D0V9HI
|
||||
Former ID |
DNC011870
|
||||
Drug Name |
Irindalone
|
||||
Drug Type |
Small molecular drug
|
||||
Indication | Inflammatory disease [ICD9: 140-229, 147, 173, 573.3, 710-719; ICD10:C11, C44, K75.9, M00-M25] | Terminated | [544636] | ||
Structure |
Download2D MOL |
||||
Formula |
C24H29FN4O
|
||||
Canonical SMILES |
C1CN(C(=O)N1)CCN2CCN(CC2)C3CC(C4=CC=CC=C34)C5=CC=C(C=C5<br />)F
|
||||
InChI |
1S/C24H29FN4O/c25-19-7-5-18(6-8-19)22-17-23(21-4-2-1-3-20(21)22)28-14-11-27(12-15-28)13-16-29-10-9-26-24(29)30/h1-8,22-23H,9-17H2,(H,26,30)/t22-,23+/m0/s1
|
||||
InChIKey |
GHAMYXPEZSUOCU-XZOQPEGZSA-N
|
||||
PubChem Compound ID | |||||
Target and Pathway | |||||
Target(s) | Sodium-dependent serotonin transporter | Target Info | Inhibitor | [533382] | |
KEGG Pathway | Serotonergic synapse | ||||
NetPath Pathway | TCR Signaling Pathway | ||||
References |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.